Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunology
Biotech
AbbVie grabs a wrench to add immunology-focused Landos Biopharma
AbbVie has grabbed a wrench to add on some new autoimmune disease options to its pipeline via the acquisition of Landos Biopharma.
Annalee Armstrong
Mar 25, 2024 9:20am
Acelyrin rebounds with psoriatic arthritis victory
Mar 11, 2024 10:59am
J&J sees ‘opportunities’ in neuro and immunology post-Ambrx buy
Jan 23, 2024 10:54am
Sanofi predicts $5B sales for 3 drugs, names 9 more blockbusters
Dec 7, 2023 6:36am
Celldex laces up next to Big Pharmas with chronic hive drug
Nov 6, 2023 10:17am
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 1:06pm